Welcome to our dedicated page for Sonendo news (Ticker: SONX), a resource for investors and traders seeking the latest updates and insights on Sonendo stock.
Sonendo, Inc. reports developments as a commercial-stage dental technology company built around the GentleWave® System for root canal therapy. The company develops and manufactures a platform that uses procedure fluid optimization, broad-spectrum acoustic energy and fluid dynamics to clean and disinfect microscopic spaces within teeth while preserving tooth structure.
SONX news commonly covers quarterly and annual results, console sales, procedure-related consumables and service revenue, gross margin, operating expense reductions and cash-flow guidance. Company updates also address commercial execution, liquidity actions such as private placements and credit facility amendments, leadership changes, and the completed divestiture of the TDO practice management software segment.
Sonendo (NASDAQ:SONX) reported preliminary 2025 results and business updates, highlighting progress toward profitability. The company posted $28.6 million revenue for 2025, 41.9% gross margin (up 460 bps), reduced operating loss to $13.5 million, adjusted EBITDA loss to $10.4 million, and free cash flow burn to $10.9 million. Sonendo expects positive free cash flow and positive adjusted EBITDA in H2 2026. The company also announced a European strategic collaboration, exclusive North America product rights, and launched FlowLogic endodontic files in Q1 2026.
Sonendo (OTC Pink: SONX), a dental technology company specializing in the GentleWave® System, has promoted John McGaugh to Chief Operating Officer from his previous role as Senior Vice President of Operations.
Under the company's strategic reset initiated in early-2024, Sonendo has achieved revenue stabilization, improved gross margins, and reduced operating expenses and cash burn. In his expanded role, McGaugh will oversee quality, manufacturing, supply chain, technical services operations, and additionally lead the capital and consumables sales teams and commercial operations.
McGaugh, who joined Sonendo in May 2023, brings over 20 years of global manufacturing operations experience, including previous leadership positions at Abbott Vascular, Boston Scientific, and American Medical Systems.
Sonendo (NYSE:SONX), a dental technology company specializing in the GentleWave® System, reported Q2 2025 financial results. Revenue was $7.4 million, down 11% year-over-year due to lower console sales from a streamlined sales team. The company showed operational improvements with gross margin increasing to 41% (up 320 basis points) and reduced loss from operations to $3.9 million.
Notable improvements include a 47% reduction in Adjusted EBITDA loss to $3.0 million and a 61% decrease in free cash flow burn to $2.6 million. The company maintained a cash position of $9.3 million with $14.2 million outstanding under its credit facility. Management reaffirmed 2025 guidance, projecting revenue of $31-32 million and gross margins of 44-46%.
Sonendo Inc. (SONX) reported its Q4 and full-year 2024 financial results, showing mixed performance with significant cost improvements despite revenue decline. Q4 revenue was $8.3 million, down from $9.0 million in Q4 2023, while full-year revenue reached $31.7 million, compared to $34.6 million in 2023.
Notable improvements include substantial gross margin expansion, with Q4 GAAP gross margin increasing to 41.1% from 25.4% year-over-year. The company significantly reduced its operating loss to $5.6 million in Q4 and $29.4 million for the full year, representing improvements of 45.2% and 50.4% respectively. Free cash flow burn decreased by 69.4% to $2.9 million in Q4.
The company maintains approximately 650 active customers for its GentleWave System. As of December 31, 2024, Sonendo had $11.6 million in cash and investments, with $15.1 million outstanding under its term loan facility.
Sonendo (OTCQX: SONX) reported Q3 2024 financial results with total revenue of $8.0 million, a 2% decrease from Q3 2023. The company showed significant improvements in margins, with GAAP gross margin rising to 41.2% and adjusted gross margin reaching 42.6%. Operating loss reduced to $7.5 million, while free cash flow burn improved by 59% year-over-year to $4.3 million. GentleWave console revenue decreased 10% to $1.9 million, maintaining an active user base of over 800 customers. The company ended the quarter with $17.3 million in cash and cash equivalents.
Sonendo (OTCQX: SONX), a dental technology company known for the GentleWave® System, has announced the postponement of its third quarter 2024 earnings conference call, which was originally scheduled for November 12th, 2024. While the company will proceed with filing its audited financial results on the planned date, management has delayed the accompanying conference call indefinitely. Commentary on post-quarter events will be provided at a later date.
Sonendo (OTCQX: SONX), a dental technology company and developer of the GentleWave® System, has scheduled its third quarter 2024 financial results announcement for November 12, 2024, after market close. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors can join via phone using specific dial-in numbers or access the live webcast through the company's investor relations website.
Sonendo (OTCQX:SONX) has launched ProControl™, a new software update for their GentleWave® G4 System designed to enhance endodontic care. The update enables endodontists to adjust procedure fluid concentration levels when using the CleanFlow™ procedure instrument, allowing for personalized treatment and improved clinical outcomes. ProControl offers optimized cleaning of complex anatomy and increased procedure efficiency, representing a significant advancement in dental technology. The system's unique ability to automatically and precisely adjust fluid concentrations during treatment sets it apart from other endodontic systems.